Results 41 to 50 of about 15,919 (234)

The new way of Dabigatran reversal – Idarucizumab

Journal of Education, Health and Sport, 2019
Since last few years a popularity of new oral anticoagulants significantly raised. There are following main direct oral anticoagulants (DOAC) used in therapy: Dabigatran, Rywaroxaban, Apixaban, Endoxaban.
Erwin Ciechański, Krystian Ciechański, Magda Ciechańska, Jarosław Szponar   +3 more
doaj   +1 more source

Broad activity against fungal phytopathogens of marine Astrosphaeriella cf. striatispora BUCS 055-1 [PDF]

Songklanakarin Journal of Science and Technology (SJST), 2021
Inhibitory activity against all five fungal phytopathogens; Colletotrichum capsici DOAC 1511, C. gloeosporioides DOAC 0782, Fusarium oxysporum DOAC 1808, F. subglutinans DOAC 0761 and Pestalotiopsis sp.
Sudarat Suanjit, Watanalai Panbangred, Apiradee Pilantanapak   +2 more
doaj   +1 more source

The use of direct acting oral anticoagulants in patients with COVID-19 infection

Journal of Community Hospital Internal Medicine Perspectives, 2021
The use of direct-acting oral anticoagulants (DOACs) has increased rapidly in the last decade; becoming the mainstay for both the prophylaxis and the treatment of venous thromboembolism in various situations including non-valvular atrial fibrillation ...
Ragia Aly, Sachin Gupta, Balraj Singh, Parminder Kaur, Kunhwa Kim, Sorab Gupta   +5 more
doaj   +1 more source

Estimated Thresholds of Minimum Necessary Adherence for Effective Treatment with Direct Oral Anticoagulants – A Retrospective Cohort Study in Health Insurance Claims Data

Patient Preference and Adherence, 2021
Lucas Wirbka, Walter Emil Haefeli, Andreas Daniel Meid On behalf of ARMIN Study GroupDepartment of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, 69120, GermanyCorrespondence: Andreas Daniel MeidDepartment of ...
Wirbka L, Haefeli WE, Meid AD
doaj  

Analýza adherence pacientů k léčbě DOAC II [PDF]

, 2023
6 Abstract Analysis of patient adherence to treatment by DOAC II Author: Natália Janáčková Tutor: doc. PharmDr. Josef Malý, Ph.D. Consultant: PharmDr. Simona Dvořáčková, Ph.D., Mgr.
Janáčková, Natália
core  

Inhospital outcomes of myocardial infarction in patients receiving direct oral anticoagulants

Рациональная фармакотерапия в кардиологии, 2023
Aim. To evaluate the clinical course and inhospital outcomes of myocardial infarction (MI) in patients receiving continuous direct oral anticoagulant (DOAC) therapy.Material and methods. Data from 390 patients treated for MI were included in the analysis.
M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina   +2 more
doaj   +1 more source

Suspected Rivaroxaban-Induced Anaphylaxis Secondary to Ingestion of Rivaroxaban and Nimesulide Without Cross-Reactivity to Dabigatran – A Case Report

Journal of Asthma and Allergy, 2023
Gediminas Gumbis,1 Inga Česnavičiūtė,1 Gabija Didžiokaitė,1,2 Daiva Gegeckienė,3 Violeta Kvedarienė4,5 1Faculty of Medicine, Vilnius University, Vilnius, Lithuania; 2Institute of Clinical Medicine, Faculty ...
Gumbis G, Česnavičiūtė I, Didžiokaitė G, Gegeckienė D, Kvedarienė V   +4 more
doaj  

SPONTANEOUS HEMOTORAX SECONDARY TO RIVAROXABANO TREATMENT

Galicia Clínica, 2020
.
, Ana Carvalho, Antonio Antunes
doaj   +1 more source

Antithrombotic therapy for secondary prevention of unprovoked venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials

Annals of Medicine, 2022
Background Extended antithrombotic treatment is recommended for secondary prevention of unprovoked venous thromboembolism (VTE), however, there is no consensus on which antithrombotic strategy is preferable.
Dandan Li, Yi Liu, Yao Song, Aiping Wen
doaj   +1 more source

Direct oral anticoagulant blood level monitoring in daily practice

Thrombosis Update, 2021
Introduction: Routine monitoring is not required in direct oral anticoagulant (DOAC) treatment, yet it is frequently performed. Guidance on the interpretation and management of DOAC level measurements is lacking and it is key to investigate which ...
R. Bavalia, J.E. Veenhuizen, R.C.C. Hengeveld, D. Braeken, A.J.W. Gulpen, H. Ten Cate, S. Middeldorp, Y.M.C. Henskens, B.A. Hutten, M. Coppens, A.K. Stroobants   +10 more
doaj   +1 more source